Seborrheic Keratosis
19
1
1
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
10.5%
2 terminated out of 19 trials
88.2%
+1.7% vs benchmark
21%
4 trials in Phase 3/4
53%
8 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (19)
Effect of 1% Andaliman Fruit Extract Cream on Facial Seborrheic Keratosis
Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors
Fast Track Diagnosis of Skin Cancer by Advanced Imaging
A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study
Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization
Study of A-101 for the Treatment of Seborrheic Keratosis
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis
Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?
An Open-Label Safety Study of A-101 Solution
A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis
A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.
Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis